High-rolling investors have positioned themselves bullish on DexCom DXCM, and it's important for retail traders to take note. \This activity came to our attention today through Benzinga's tracking of publicly available options data. The identities of these investors are uncertain, but such a significant move in DXCM often signals that someone has privileged information.
Today, Benzinga's options scanner spotted 8 options trades for DexCom. This is not a typical pattern.
The sentiment among these major traders is split, with 37% bullish and 37% bearish. Among all the options we identified, there was one put, amounting to $27,282, and 7 calls, totaling $661,740.
Predicted Price Range
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $70.0 and $115.0 for DexCom, spanning the last three months.
Volume & Open Interest Trends
In today's trading context, the average open interest for options of DexCom stands at 764.62, with a total volume reaching 799.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in DexCom, situated within the strike price corridor from $70.0 to $115.0, throughout the last 30 days.
DexCom 30-Day Option Volume & Interest Snapshot
Noteworthy Options Activity:
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DXCM | CALL | TRADE | NEUTRAL | 12/20/24 | $8.5 | $8.3 | $8.4 | $70.00 | $197.4K | 1.5K | 245 |
| DXCM | CALL | TRADE | BULLISH | 12/20/24 | $6.2 | $6.1 | $6.2 | $75.00 | $143.8K | 855 | 286 |
| DXCM | CALL | SWEEP | BULLISH | 01/16/26 | $14.3 | $14.0 | $14.3 | $80.00 | $127.2K | 119 | 90 |
| DXCM | CALL | TRADE | BEARISH | 12/20/24 | $4.1 | $4.0 | $4.0 | $80.00 | $80.0K | 362 | 100 |
| DXCM | CALL | TRADE | NEUTRAL | 12/18/26 | $23.6 | $22.8 | $23.2 | $70.00 | $46.4K | 99 | 20 |
About DexCom
Dexcom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery.
Following our analysis of the options activities associated with DexCom, we pivot to a closer look at the company's own performance.
DexCom's Current Market Status
- With a volume of 1,238,195, the price of DXCM is down -0.24% at $69.38.
- RSI indicators hint that the underlying stock may be approaching overbought.
- Next earnings are expected to be released in 6 days.
Expert Opinions on DexCom
1 market experts have recently issued ratings for this stock, with a consensus target price of $120.0.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. Click here for access. * Consistent in their evaluation, an analyst from RBC Capital keeps a Outperform rating on DexCom with a target price of $120.
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest DexCom options trades with real-time alerts from Benzinga Pro.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
